Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1. Frank N, Geor RJ, Bailey SR, et al. Equine metabolic syndrome. J Vet Intern Med 2010;24:467–475.
-
2. Johnson PJ, Wiedmeyer CE, LaCarrubba A, et al. Diabetes, insulin resistance, and metabolic syndrome in horses. J Diabetes Sci Technol 2012;6:534–540.
-
3. Frank N, Tadros EM. Insulin dysregulation. Equine Vet J 2014;46:103–112.
-
4. Tóth F, Frank N, Martin-Jiménez T, et al. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses. Equine Vet J 2010;42:149–155.
-
5. Hoffman RM, Boston RC, Stefanovski D, et al. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings. J Anim Sci 2003;81:2333–2342.
-
6. Tóth F, Frank N, Elliot SB, et al. Optimisation of the frequently sampled intravenous glucose tolerance test to reduce urinary glucose spilling in horses. Equine Vet J 2009;41:844–851.
-
7. Freestone JF, Wolfsheimer KJ, Kamerling SG, et al. Exercise induced hormonal and metabolic changes in Thoroughbred horses: effects of conditioning and acepromazine. Equine Vet J 1991;23:219–223.
-
8. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456–1467.
-
9. Boston RC, Stefanovski D, Moate PJ, et al. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 2003;5:1003–1015.
-
10. Haschek WM, Rousseaux CG, Wallig MA. Pancreas. In: Fundamentals of toxicologic pathology. 2nd ed. London: Elsevier, 2010;237–260.
-
11. Steiner DJ, Kim A, Miller K, et al. Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets 2010;2:135–145.
-
12. Hawkins KL, Summers BA, Kuhajda FP, et al. Immunocytochemistry of normal pancreatic islets and spontaneous islet cell tumors in dogs. Vet Pathol 1987;24:170–179.
-
13. Bamford NJ, Baskerville CL, Harris PA, et al. Postprandial glucose, insulin, and glucagon-like peptide-1 responses of different equine breeds adapted to meals containing micronized maize. J Anim Sci 2015;93:3377–3383.
-
14. de Laat MA, McGree JM, Sillence MN. Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation. Am J Physiol Endocrinol Metab 2016;310:E61–E72.
-
15. Chameroy KA, Frank N, Elliott SB, et al. Comparison of plasma active glucagon-like peptide 1 concentrations in normal horses and those with equine metabolic syndrome and in horses placed on a high-grain diet. J Equine Vet Sci 2016;40:16–25.
-
16. Gosmanov NR, Szoke E, Israelian Z, et al. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 2005;28:1124–1131.
-
17. Ferrannini E, Muscelli E, Natali A, et al. Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia 2007;50:2342–2347.
-
18. Chang-Chen KJ, Mullur R, Bernal-Mizrachi E. Beta-cell failure as a complication of diabetes. Rev Endocr Metab Disord 2008;9:329–343.
-
19. Yang K, Gotzmann J, Kuny S, et al. Five stages of progressive β-cell dysfunction in the laboratory Nile rat model of type 2 diabetes. J Endocrinol 2016;229:343–356.
-
20. Dunbar LK, Mielnicki KA, Dembek KA, et al. Evaluation of four diagnostic tests for insulin dysregulation in adult light-breed horses. J Vet Intern Med 2016;30:885–891.
-
21. Treiber KH, Kronfeld DS, Hess TM, et al. Use of proxies and reference quintiles obtained from minimal model analysis for determination of insulin sensitivity and pancreatic beta-cell responsiveness in horses. Am J Vet Res 2005;66:2114–2121.
Advertisement
Immunohistochemical expression of insulin, glucagon, and somatostatin in pancreatic islets of horses with and without insulin resistance
Abstract
OBJECTIVE To assess insulin, glucagon, and somatostatin expression within pancreatic islets of horses with and without insulin resistance.
ANIMALS 10 insulin-resistant horses and 13 insulin-sensitive horses.
PROCEDURES For each horse, food was withheld for at least 10 hours before a blood sample was collected for determination of serum insulin concentration. Horses with a serum insulin concentration < 20 μU/mL were assigned to the insulin-sensitive group, whereas horses with a serum insulin concentration > 20 μU/mL underwent a frequently sampled IV glucose tolerance test to determine sensitivity to insulin by minimal model analysis. Horses with a sensitivity to insulin < 1.0 × 10−4 L•min−1•mU−1 were assigned to the insulin-resistant group. All horses were euthanized with a barbiturate overdose, and pancreatic specimens were harvested and immunohistochemically stained for determination of insulin, glucagon, and somatostatin expression in pancreatic islets. Islet hormone expression was compared between insulin-resistant and insulin-sensitive horses.
RESULTS Cells expressing insulin, glucagon, and somatostatin made up approximately 62%, 12%, and 7%, respectively, of pancreatic islet cells in insulin-resistant horses and 64%, 18%, and 9%, respectively, of pancreatic islet cells in insulin-sensitive horses. Expression of insulin and somatostatin did not differ between insulin-resistant and insulin-sensitive horses, but the median percentage of glucagon-expressing cells in the islets of insulin-resistant horses was significantly less than that in insulin-sensitive horses.
CONCLUSIONS AND CLINICAL RELEVANCE Results suggested that, in insulin-resistant horses, insulin secretion was not increased but glucagon production might be downregulated as a compensatory response to hyperinsulinemia.
Contributor Notes
Dr. Ehrensing's present address is Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824.
Powered by PubFactory